Christina Ackermann is EVP AND GENERAL COUNSEL of Bausch Health Companies Inc.. Currently has a direct ownership of 162,240 shares of BHC, which is worth approximately $1.54 Million. The most recent transaction as insider was on Mar 10, 2022, when has been sold 839 shares (Common Shares, no par value) at a price of $22.56 per share, resulting in proceeds of $18,928. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 162K
0% 3M change
0% 12M change
Total Value Held $1.54 Million

CHRISTINA ACKERMANN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 10 2022
SELL
Payment of exercise price or tax liability
$18,928 $22.56 p/Share
839 Reduced 0.51%
162,240 Common Shares, no par ...
Mar 03 2022
SELL
Payment of exercise price or tax liability
$163,523 $23.61 p/Share
6,926 Reduced 4.07%
163,079 Common Shares, no par ...
Feb 27 2022
SELL
Payment of exercise price or tax liability
$390,282 $24.35 p/Share
16,028 Reduced 8.62%
170,005 Common Shares, no par ...
Feb 27 2022
BUY
Exercise of conversion of derivative security
-
24,292 Added 11.55%
186,033 Common Shares, no par ...
Aug 27 2021
SELL
Payment of exercise price or tax liability
$145,242 $28.95 p/Share
5,017 Reduced 3.01%
161,741 Common Shares, no par ...
Jun 02 2021
SELL
Open market or private sale
$3,857,732 $31.83 p/Share
121,198 Reduced 42.09%
166,758 Common Shares, no par ...
Jun 02 2021
BUY
Exercise of conversion of derivative security
$1,799,790 $14.85 p/Share
121,198 Added 29.62%
287,956 Common Shares, no par ...
Mar 11 2021
SELL
Payment of exercise price or tax liability
$26,125 $32.82 p/Share
796 Reduced 0.48%
166,758 Common Shares, no par ...
Mar 10 2021
SELL
Payment of exercise price or tax liability
$724,021 $32.97 p/Share
21,960 Reduced 11.59%
167,554 Common Shares, no par ...
Mar 08 2021
BUY
Grant, award, or other acquisition
-
25,980 Added 12.06%
189,514 Common Shares, no par ...
Mar 08 2021
BUY
Exercise of conversion of derivative security
-
8,455 Added 4.92%
163,534 Common Shares, no par ...
Mar 03 2021
BUY
Grant, award, or other acquisition
-
36,250 Added 18.95%
155,079 Common Shares, no par ...
Mar 01 2021
SELL
Payment of exercise price or tax liability
$168,631 $31.42 p/Share
5,367 Reduced 4.32%
118,829 Common Shares, no par ...

Also insider at

GRAY
GRAYBUG VISION, INC. Healthcare
BLCO
Bausch & Lomb Corp Healthcare
VRNA
Verona Pharma plc Healthcare
CA

Christina Ackermann

EVP AND GENERAL COUNSEL
Vaughan, A6

Track Institutional and Insider Activities on BHC

Follow Bausch Health Companies Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BHC shares.

Notify only if

Insider Trading

Get notified when an Bausch Health Companies Inc. insider buys or sells BHC shares.

Notify only if

News

Receive news related to Bausch Health Companies Inc.

Track Activities on BHC